Keratan sulfate proteoglycans in pancreatic cancer: From stromal architects to potential therapeutic targets
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026
DOI: 10.1016/j.bbcan.2026.189682 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Wenjing Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shandong First Medical University, Jinan 250117, Shandong, China; Department of Pharmacy, Jining Medical University, Rizhao 2…. Hauptthemen laut MEDLINE: Keratan Sulfate, Pancreatic Neoplasms, Proteoglycans, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 112 Literaturangaben. Gefördert von: Jining Medical University, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Pancreatic cancer features a dense desmoplastic stroma that drives therapeutic resistance and immune evasion. Traditionally viewed as inert scaffolds, keratan sulfate proteoglycans (KSPGs) now emerge as active signaling modulators within this tumor microenvironment. This review elucidates the multifaceted roles of KSPGs and their specific sulfation patterns in pancreatic ductal adenocarcinoma (PDAC). We detail how KSPG core proteins orchestrate collagen fibrillogenesis and tissue biomechanics, while highly sulfated keratan sulfate (KS) chains act as biochemical traps sequestering oncogenic ligands and chemokines. This biochemical interplay synergistically reprograms signaling cascades to govern tumor plasticity and metastasis. Crucially, KSPGs mediate immune exclusion by impeding CD8+ T cell infiltration and sustaining chronic inflammation via damage-associated molecular patterns (DAMPs). Finally, we highlight the translational potential of targeting KS sulfation via carbohydrate sulfotransferases (CHSTs) as a promising strategy for stromal normalization to overcome current therapeutic bottlenecks in PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Shandong First Medical University, Jinan 250117, Shandong, China; Department of Pharmacy, Jining Medical University, Rizhao 276826, Shandong, China.
- Department of Pharmacy, Jining Medical University, Rizhao 276826, Shandong, China.
- Department of Pharmacy, Jining Medical University, Rizhao 276826, Shandong, China; School of Pharmacy, Shandong Medical and Pharmaceutical University, Yantai 264003, Shandong, China.
- Department of Pharmacy, Jining Medical University, Rizhao 276826, Shandong, China. Electronic address: lcanatomy@163.com.
- Department of Pharmacy, Jining Medical University, Rizhao 276826, Shandong, China. Electronic address: mianyigao@163.com.
- Department of Pharmacy, Jining Medical University, Rizhao 276826, Shandong, China. Electronic address: zhangyt@mail.jnmc.edu.cn.
Förderung
- Jining Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Liang, W., Lyu, D., Fan, K., Liu, C., Ren, Q., Gao, H., & Zhang, Y. (2026). Keratan sulfate proteoglycans in pancreatic cancer: From stromal architects to potential therapeutic targets. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189682
Vancouver
Liang W, Lyu D, Fan K, Liu C, Ren Q, Gao H, et al. Keratan sulfate proteoglycans in pancreatic cancer: From stromal architects to potential therapeutic targets. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189682
BibTeX
@article{Liang2026,
author = {Liang, Wenjing and Lyu, Dongyi and Fan, Kunzheng and Liu, Chao and Ren, Qiang and Gao, Huijie and Zhang, Yuntao},
title = {Keratan sulfate proteoglycans in pancreatic cancer: From stromal architects to potential therapeutic targets},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
doi = {10.1016/j.bbcan.2026.189682}
}
EUVIMED